My concerns at this point are that the quarterly may show slow uptick in actual revenue, as expected by some (otherwise they probably wouldn't have needed to raise capital) and that this may reflect that even new contracts signed will require some time to fully convert to recurring revenues.
Thoughts?
- Forums
- ASX - By Stock
- PCK
- PainChek General Discussion
PainChek General Discussion, page-3911
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.0¢ |
Change
0.001(3.45%) |
Mkt cap ! $49.11M |
Open | High | Low | Value | Volume |
2.9¢ | 3.0¢ | 2.9¢ | $16.16K | 553.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 41868 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 354462 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 41868 | 0.029 |
4 | 858114 | 0.028 |
5 | 874074 | 0.027 |
6 | 1463115 | 0.026 |
5 | 1239601 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 322462 | 1 |
0.031 | 350000 | 2 |
0.032 | 421538 | 2 |
0.033 | 100000 | 1 |
0.034 | 108791 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online